Cardiac biomarkers and risk of atrial fibrillation in chronic kidney disease: The CRIC Study
Journal of the American Heart Association Aug 08, 2019
Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, et al. - In this prospective study, researchers investigated 3,053 patients with chronic kidney disease to assess the risk of incident atrial fibrillation (AF) in these individuals in relation to cardiac biomarkers of myocardial stretch, injury, inflammation, and fibrosis. Participants in the multicenter Chronic Renal Insufficiency Cohort study were free of AF at baseline. NT-proBNP (N-terminal pro-B-type natriuretic peptide), high-sensitivity troponin T, galectin-3, growth differentiation factor-15, and soluble ST-2 were measured at baseline as cardiac biomarkers. A hospitalization for AF defined incident AF (“AF event”). Participants were observed over a median duration of 8 years. In the study sample, strong links were found between higher NT-proBNP and high-sensitivity troponin T levels, and the risk of incident AF. The possible implication of increased atrial myocardial stretch and myocardial cell injury in the high burden of AF in patients with chronic kidney disease was also suggested.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries